Health tech company Inato developed an AI-powered patient pre-screening tool to make it easier and faster for research sites to assess patient eligibility for clinical trial opportunities. | Health ...

Specifically, the VHA is making lecanemab available, provided patients and doctors receive prior authorization and meet inclusion ... There are several more exclusion criteria, including patients ...

Exigent Research and ConcertAI announced a major multi-year partnership to assure potentially lifesaving clinical trials are available to the broadest population of patients possible, combining the ...